Diabetic Macular Edema (DME) Active Not Recruiting Phase Trials for Aflibercept (DB08885)

Also known as: Diabetic Macular Edema(DME) / Diabetic Macular Oedema / Macular Edema, Diabetic / Diabetic Macular Edema / Macular edema due to diabetes mellitus (disorder) / Diabetic retinal oedema / Diabetic retinal edema

IndicationStatusPhase
DBCOND0060562 (Diabetic Macular Edema (DME))Active Not RecruitingNot Available
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT02645266Mean Visual Acuity Changes Following Five Injections of AfliberceptTreatment
NCT03297684Assessment of Biomarker Profile in Diabetic Macular Edema With Intravitreal Aflibercept Injection